Caris Life Sciences, Inc. (CAI) Stock Analysis

Caris Life Sciences, Inc. (CAI) Stock Analysis — AI Research | MarketCI

CAI

Market Closed

Caris Life Sciences, Inc.

NASDAQHealthcare Biotechnology

1.77K employees

CEO: David Dean Halbert

Founded: 2025

$14.96

+$0.00(+NaN%)

Market Cap

4.23B

Beta

1.09

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

CAI Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for CAI built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$13.02

AI Price Target

Machine learning • Price prediction

$15.45

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

3.35

Quality Score

Financial strength rating

8.00

AI Investment Grade

Deep analysis of filings & news

62.00

Key Investment Highlights

Important factors affecting CAI investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

47.37% Poor

Conditions Met

18.00/38.00

Due Diligence Score

47.37%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Pass
	Pass
	Fail
	Pass
	Pass

Showing 1 to 6 of 46 conditions